Skip to main content
. 2018 Aug 8;11(5):1225–1231. doi: 10.1016/j.tranon.2018.07.016

Table 4.

Diagnostic Performance of One-Gene vs. a Plasma lncRNA Signature for Lung Cancer Diagnosis in a Validation Set

Accuracy Sensitivity (95% CI) Specificity (95% CI)
SNHG1 80.33% (68.16%-89.40%) 76.92% (60.67%-88.87) 86.36% (65.09%-97.09%)
RMRP 72.13% (59.17%-82.85%) 61.54% (44.62%-76.64%) 90.91% (70.84%-98.88%)
A plasma lncRNA signature 83.62% (71.91%-91.85%) 82.05% (66.47%-92.46%) 86.36% (65.09%-97.09%)